Get the facts on cost and Empaveli, ... On these pages, you can find insurance information, details on drug assistance programs, and links to savings cards and other services.

Empaveli is only available through a restricted Risk Evaluation and Mitigation Strategy (REMS) program. The FDA requires REMS programs for some medicines that have serious safety concerns.

A program called ApellisAssist is available for Empaveli. For more information and to find out if you’re eligible for support, call 866-MY-APL-ASSIST (866-692-7527) or visit the program website .

EMPAVELI Compliance Rate: 97%. Warning! ... SYFOVRE revenue fell short of expectations due to funding shortages at third-party co-pay assistance programs and a larger-than-expected inventory drawdown.

Revenue impacted by inventory and funding shortage at co-pay assistance programs QoQ total injection growth of 4% Delivered approximately 92,000 SYFOVRE doses to physician offices, including ...

Reports Q1 revenue $166.8M, consensus $194.88M. “In the first quarter, we were pleased to see continued growth in SYFOVRE injection demand-a key in ...

Empaveli (pegcetacoplan) is a prescription drug used to treat a rare type of blood disorder. Empaveli can cause side effects that range from mild to serious, including infection and diarrhea.